Viral Vector Contract Development And Manufacturing Organization (CDMO) Global Market Report 2026
상품코드:1957918
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
바이러스 벡터 수탁 개발 제조(CDMO) 시장 규모는 최근 급성장하고 있습니다. 2025년 14억 7,000만 달러에서 2026년에는 17억 달러에 이르고, CAGR 15.6%의 성장이 전망되고 있습니다. 지난 수년간의 성장은 유전자치료제 임상 파이프라인의 확대, 바이러스 벡터 생산의 조기 외주화, 학술 연구 협력의 확대, 생명공학 기업의 자체 생산 능력의 한계, 바이러스 벡터에 대한 규제 당국의 승인 증가 등이 주요 요인으로 꼽힙니다.
바이러스 벡터 수탁 개발 제조 기관(CDMO) 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 30억 1,000만 달러에 이르고, CAGR은 15.3%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 유전자 및 세포치료제의 상업화 진전, 전용 바이러스 벡터 시설에 대한 투자 증가, 확장 가능한 제조 플랫폼에 대한 수요 증가, 세계 CDMO 파트너십 확대, 고수율 벡터 생산 기술 발전 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 대규모 바이러스 벡터 생산 능력 확대, 일회용 제조 기술 채택 증가, 엔드투엔드 CDMO 서비스에 대한 수요 증가, 규제 준수 cGMP 시설에 대한 관심 증가, 벡터 제조에 대한 고급 분석 기술 통합 강화 등이 있습니다.
유전자 치료 연구에 대한 투자 증가는 바이러스 벡터 위탁개발생산기관(CDMO) 시장의 확대를 촉진할 것으로 예측됩니다. 유전자 치료 연구는 인간 세포 내 유전자를 변형하거나 조절하는 기술 개발에 초점을 맞추고 있으며, 유전성 질환을 치료하고 다양한 질병을 퇴치하는 것을 목표로 하고 있습니다. 불치병으로 여겨졌던 유전성 질환에 대한 지속적 또는 일회성 치료법을 제공할 수 있는 잠재력을 가지고 있기 때문에 이 분야에 대한 자금 지원이 증가하고 있으며, 헬스케어 분야의 선구자 및 투자자들로부터 많은 관심을 받고 있습니다. 바이러스 벡터 CDMO는 치료용 유전자를 안전하고 효율적으로 전달하기 위해 필수적인 고품질 바이러스 벡터를 생산할 수 있는 전문성과 최첨단 제조 역량을 제공함으로써 유전자치료제 개발에 기여하고 있습니다. 예를 들어, 2025년 7월 영국 정부기관인 생명과학청은 세계 최고 수준의 안전성과 AI 대응력을 갖춘 의료 데이터 플랫폼 구축을 위해 최대 8억 달러(6억 파운드)를 투자하겠다고 밝힌 바 있습니다. 이를 통해 유전체 데이터, 진단 데이터, 임상 데이터를 인구 규모로 통합하고, NHS(국민보건서비스) 및 광범위한 헬스케어 데이터를 연구 시험 및 AI 기반 투자에 대한 세계 거점으로 전환할 수 있습니다. 이처럼 유전자 치료 연구 자금의 급증은 바이러스 벡터 CDMO 시장의 성장을 견인하고 있습니다.
바이러스 벡터 CDMO 시장의 주요 기업들은 확장성과 신뢰성을 겸비한 생산을 실현하기 위해 혁신적인 AAV 제조 솔루션을 우선적으로 도입하고 있습니다. 이러한 AAV 솔루션은 유전자 치료에 사용되는 안전하고 활성도가 높은 아데노부수체 바이러스 벡터를 효율적으로 생산할 수 있도록 설계된 전문 기술과 시스템을 포함하고 있습니다. 예를 들어, 2025년 8월 미국 CDMO 기업인 프로바이오(ProBio)는 뉴저지 주 호프웰에 위치한 128,000평방피트 규모의 최첨단 시설에서 cGMP를 준수하는 AAV 제조 서비스를 개시했습니다. 이는 고품질 바이러스 벡터에 대한 급증하는 수요에 대응하는 한편, 프로바이오의 최첨단 유전자치료제 개발 의지를 강조하기 위한 것입니다. 호프웰 공장은 엄격한 국제 규정 및 품질 가이드라인에 따라 엔드 투 엔드 AAV 제조를 실현하도록 특별히 설계되었습니다. 현재 프로바이오사는 GMP 준수 플라스미드 DNA 생산, AAV 벡터 제조, 최종 의약품용 무균 충전 및 포장까지 미국 단일 거점에서 원활하게 통합된 서비스를 제공합니다. 이 통합 모델을 통해 모니터링 체계를 강화하고, 이송 위험을 최소화하며, 전체 의약품 개발 프로세스의 타임라인을 단축할 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
A viral vector contract development and manufacturing organization (CDMO) is a specialized firm that concentrates on developing and producing viral vectors at scale for cutting-edge biological treatments. It delivers the essential technical expertise, facilities, and regulatory adherence required to handle the full viral vector production process.
Viral vector contract development and manufacturing organizations (CDMO) provide key services like process development, manufacturing, analytical testing, fill-finish, and more. Process development in pharmaceutical manufacturing entails designing and refining production processes to achieve efficient, scalable, and consistent results. Various vector types encompass adenoviral vectors, lentiviral vectors, adeno-associated viral vectors, retroviral vectors, and others, with workflows including upstream manufacturing and downstream manufacturing. Applications span gene therapy, vaccines, cell therapy, and beyond, serving end-users such as pharmaceutical and biotechnology companies, academic and research institutes, and others.
Tariffs are impacting the viral vector CDMO market by increasing the cost of imported bioreactors, filtration systems, single-use consumables, analytical instruments, and cold chain equipment used in upstream and downstream manufacturing. North America and Europe are most affected due to reliance on specialized imported bioprocessing equipment, while Asia-Pacific faces cost pressure on facility expansion projects. These tariffs are increasing capital expenditure and operational costs for CDMOs and their clients. However, they are also encouraging localized equipment sourcing, regional manufacturing ecosystem development, and long-term investments in domestic bioprocess infrastructure.
The viral vector contract development and manufacturing organization (cdmo) market research report is one of a series of new reports from The Business Research Company that provides viral vector contract development and manufacturing organization (cdmo) market statistics, including viral vector contract development and manufacturing organization (cdmo) industry global market size, regional shares, competitors with a viral vector contract development and manufacturing organization (cdmo) market share, detailed viral vector contract development and manufacturing organization (cdmo) market segments, market trends and opportunities, and any further data you may need to thrive in the viral vector contract development and manufacturing organization (cdmo) industry. This viral vector contract development and manufacturing organization (cdmo) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viral vector contract development and manufacturing organization (cdmo) market size has grown rapidly in recent years. It will grow from $1.47 billion in 2025 to $1.7 billion in 2026 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to growing clinical pipeline of gene therapies, early outsourcing of viral vector production, expansion of academic research collaborations, limited in-house manufacturing capabilities of biotech firms, increasing regulatory approvals for viral vectors.
The viral vector contract development and manufacturing organization (cdmo) market size is expected to see rapid growth in the next few years. It will grow to $3.01 billion in 2030 at a compound annual growth rate (CAGR) of 15.3%. The growth in the forecast period can be attributed to rising commercialization of gene and cell therapies, increasing investments in dedicated viral vector facilities, growing demand for scalable manufacturing platforms, expansion of global cdmo partnerships, advances in high-yield vector production technologies. Major trends in the forecast period include expanding capacity for large-scale viral vector production, increasing adoption of single-use manufacturing technologies, growing demand for end-to-end cdmo services, rising focus on regulatory-compliant cGMP facilities, enhanced integration of advanced analytics in vector manufacturing.
The rising investment in gene therapy research is set to fuel expansion in the viral vector contract development and manufacturing organization (CDMO) market. Gene therapy research centers on developing techniques to modify or control genes in human cells, aiming to treat genetic disorders or fight diverse diseases. Funding for this field is increasing because of its promise to deliver lasting or one-time cures for genetic conditions that were once incurable, sparking keen interest from healthcare pioneers and investors alike. Viral vector CDMOs aid gene therapy efforts by providing specialized expertise and cutting-edge manufacturing capabilities to produce top-tier viral vectors, essential for safely and efficiently delivering therapeutic genes. For instance, in July 2025, the Office for Life Sciences-a UK government department-announced a commitment of up to $800 million (£600 million) to build one of the world's most advanced, secure, and AI-ready health data platforms. This initiative will merge genomic, diagnostic, and clinical data at a population scale, turning NHS and wider healthcare data into a global center for research trials and AI-driven investments. Thus, the surge in gene therapy research funding is propelling growth in the viral vector CDMO market.
Major players in the viral vector CDMO market are prioritizing innovative AAV manufacturing solutions to enable scalable, reliable production. These AAV solutions encompass specialized techniques and systems designed for the efficient creation of safe, potent adeno-associated virus vectors used in gene therapy. For example, in August 2025, ProBio-a U.S.-based CDMO-introduced cGMP AAV manufacturing services at its state-of-the-art 128,000 sq. ft. facility in Hopewell, New Jersey. This initiative addresses the surging need for premium viral vectors and underscores ProBio's commitment to advancing cutting-edge gene therapies. The Hopewell site is specifically engineered to deliver end-to-end AAV manufacturing under stringent global regulatory and quality guidelines. ProBio now offers seamless, integrated services-including GMP plasmid DNA production, AAV vector manufacturing, and sterile fill/finish for final drug products-all from one U.S. site. This unified model improves oversight, minimizes transfer risks, and accelerates timelines throughout the drug development process.
In May 2023, Siegfried, a Switzerland-based life sciences firm, purchased a 95% stake in DINAMIQS for an undisclosed sum. Through this acquisition, Siegfried plans to expand DINAMIQS' capabilities to commercial scale, establishing it as a top biotech CDMO for cell and gene therapies. The deal bolsters Siegfried's footprint in the biologics field and promises significant mid- to long-term growth in a fast-growing market. DINAMIQS, based in Switzerland, offers full contract development and manufacturing services for viral vectors.
Major companies operating in the viral vector contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group AG, WuXi AppTec, Samsung Biologics Co. Ltd., FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Genesail Biotech Co. Ltd., CEVEC Pharmaceuticals, Cell and Gene Therapy Catapult, CoJourney, Applied Biological Laboratories Inc.
North America was the largest region in the viral vector contract development and manufacturing organization (CDMO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector contract development and manufacturing organization (cdmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the viral vector contract development and manufacturing organization (cdmo) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viral vector contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as cell line development, preclinical material production, quality control testing, and supply chain management. The market value includes the value of related goods sold by the service provider or included within the service offering. The viral vector contract development and manufacturing organization (CDMO) market also includes sales of helper plasmids, packaging cell lines, producer cell banks, and purified viral vector components. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses viral vector contract development and manufacturing organization (cdmo) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viral vector contract development and manufacturing organization (cdmo) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral vector contract development and manufacturing organization (cdmo) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Service Type: Process Development; Manufacturing; Analytical Testing; Fill-Finish; Other Service Types
2) By Vector Type: Adenoviral Vectors; Lentiviral Vectors; Adeno-Associated Viral Vectors; Retroviral Vectors; Other Vector Types
3) By Workflow: Upstream Manufacturing; Downstream Manufacturing
4) By Application: Gene Therapy; Vaccines; Cell Therapy; Other Applications
5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
Subsegments:
1) By Process Development: Upstream Process Development; Downstream Process Development; Analytical Development; Process Characterization
2) By Manufacturing: Clinical Manufacturing; Commercial Manufacturing; cGMP Manufacturing; Cell Bank Production; Fill-Finish Services
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Expanding Capacity For Large-Scale Viral Vector Production
4.2.2 Increasing Adoption Of Single-Use Manufacturing Technologies
4.2.3 Growing Demand For End-To-End Cdmo Services
4.2.4 Rising Focus On Regulatory-Compliant Cgmp Facilities
4.2.5 Enhanced Integration Of Advanced Analytics In Vector Manufacturing
5. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Analysis Of End Use Industries
5.1 Pharmaceutical And Biotechnology Companies
5.2 Gene Therapy Developers
5.3 Vaccine Manufacturers
5.4 Cell Therapy Companies
5.5 Academic And Research Institutes
6. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Size, Comparisons And Growth Rate Analysis
7.3. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Segmentation
9.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Process Development, Manufacturing, Analytical Testing, Fill-Finish, Other Service Types
9.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Vector Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.3. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Upstream Manufacturing, Downstream Manufacturing
9.4. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Gene Therapy, Vaccines, Cell Therapy, Other Applications
9.5. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Other End-Users
9.6. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Process Development, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Upstream Process Development, Downstream Process Development, Analytical Development, Process Characterization
9.7. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Manufacturing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Analytical Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Fill-Finish, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Aseptic Filling, Lyophilization, Final Packaging, Cold Chain Management, Labeling And Serialization
9.10. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Other Service Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis
10.1. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
11.1. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
12.1. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
13.1. India Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
14.1. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
15.1. Australia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
16.1. Indonesia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
17.1. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
18.1. Taiwan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
19.1. South East Asia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
20.1. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
21.1. UK Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
22.1. Germany Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
23.1. France Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
24.1. Italy Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
25.1. Spain Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
26.1. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
27.1. Russia Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
28.1. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
29.1. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
30.1. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
31.1. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
32.1. Brazil Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
33.1. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
34.1. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Viral Vector Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Segmentation By Vector Type, Segmentation By Workflow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Regulatory and Investment Landscape
36. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles
36.1. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Company Profiles
36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. WuXi AppTec Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Samsung Biologics Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies
FUJIFILM Biotechnologies, Oxford Biomedica Plc, Hillgene, Takara Bio Inc., SkyPharma Production SAS, GeneScript ProBio, Obio Technology Corp. Ltd., VectorBuilder, Charles River Laboratories Pvt. Ltd., Creative Biogene, Esco Aster Pte. Ltd., Genesail Biotech Co. Ltd., CEVEC Pharmaceuticals, Cell and Gene Therapy Catapult, CoJourney
38. Global Viral Vector Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Viral Vector Contract Development And Manufacturing Organization (CDMO) Market
40. Viral Vector Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies
40.1 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Countries Offering Most New Opportunities
40.2 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Segments Offering Most New Opportunities
40.3 Viral Vector Contract Development And Manufacturing Organization (CDMO) Market In 2030 - Growth Strategies
